Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689K Buy
5,358
+182
+4% +$21.3K 0.46% 41
2026
Q1
$623K Buy
5,176
+207
+4% +$23.9K 0.46% 44
2025
Q4
$523K Buy
4,969
+1,121
+29% +$105K 0.39% 47
2025
Q3
$323K Buy
3,848
+354
+10% +$29.2K 0.25% 57
2025
Q2
$277K Buy
3,494
+655
+23% +$52.1K 0.23% 58
2025
Q1
$255K Sell
2,839
-35
-1% -$3.27K 0.23% 61
2024
Q4
$286K Buy
+2,874
New +$296K 0.25% 57

Other funds holding MRK

Womack Financial's MRK Position: Q2 2026 in Review

Womack Financial increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $21.3K and bringing the position to 5,358 shares worth $689K. The position accounts for 0.46% of the portfolio, ranked #41.

Womack Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,817 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Womack Financial held 5,358 shares of Merck worth $689K as of Q2 2026.
  • Womack Financial bought 182 Merck shares in Q2 2026, an estimated $21.3K.
  • Merck made up 0.46% of Womack Financial's portfolio in Q2 2026, its #41 holding.
  • Womack Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,817 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Womack Financial's 13F filing for Q2 2026, filed 14 Aug 2026.